2023
Time to Diagnosis and Treatment of Non-small Cell Lung Cancer in Patients Undergoing Lung Cancer Screening
Bernstein E, DeRycke E, Han L, Bastian L, Bade B, Lerz K, Kravetz J, Carino M, Rose M, Akgun K, Cain H. Time to Diagnosis and Treatment of Non-small Cell Lung Cancer in Patients Undergoing Lung Cancer Screening. 2023, a2734-a2734. DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2734.Peer-Reviewed Original Research
2022
Post-9/11 deployment history and the incidence of breast cancer among women veterans
Gaffey A, Han L, Ramsey C, Skanderson M, Dziura J, Driscoll M, Burg M, Brandt C, Bastian L, Haskell S. Post-9/11 deployment history and the incidence of breast cancer among women veterans. Annals Of Epidemiology 2022, 77: 98-102. PMID: 36470323, DOI: 10.1016/j.annepidem.2022.11.010.Peer-Reviewed Original ResearchConceptsOEF/OIF deploymentBreast cancerWomen veteransHealthcare utilizationHormone replacement therapy useRetrospective cohort studyVeterans Affairs (VA) careHealthy soldier effectOEF/OIFCohort studyTherapy useBC incidenceHormonal contraceptivesLifestyle factorsPrimary careBC diagnosisLower incidenceOperations Enduring Freedom/Iraqi FreedomWomenIncidenceGreater likelihoodIraqi FreedomVeteransCancerCareThe Complexity of Sex-Based Cancer Screenings for Veterans with Gender-Related Diagnoses in VA Care
Warren A, Brandt C, Bastian L, Zeng Q, Black A, Goulet J. The Complexity of Sex-Based Cancer Screenings for Veterans with Gender-Related Diagnoses in VA Care. Annals Of LGBTQ Public And Population Health 2022, 3: 135-141. DOI: 10.1891/lgbtq-2021-0010.Peer-Reviewed Original ResearchElectronic health recordsVeterans Health AdministrationNational electronic health recordCervical cancerCancer screeningVA careProstate cancer screeningPSA testingDiagnostic codesVA facilitiesMale veteransHealth AdministrationSex-specific careFemale veteransCancer screenDiagnosisCareHealth recordsVeteransSexCancerOriginal sex
2014
Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans
Shofer S, Beyea M, Li S, Bastian LA, Wahidi MM, Kelley M, Lipkus IM. Feasibility of using an epigenetic marker of risk for lung cancer, methylation of p16, to promote smoking cessation among US veterans. BMJ Open Respiratory Research 2014, 1: e000032. PMID: 25478181, PMCID: PMC4212704, DOI: 10.1136/bmjresp-2014-000032.Peer-Reviewed Original ResearchLung cancer riskLung cancerSmoking cessationCancer riskMethylated p16Time of enrollmentAcceptance of testingCent of participantsAirway obstructionActive smokersCurrent smokersCessation assistanceTobacco exposureCessation ratesUS veteransEpigenetic markersSmokersMethylation of p16P16 methylationCancerP16SmokingEducational materialsRiskEducational presentationsImproving care of chronic conditions for women veterans: identifying opportunities for comparative effectiveness research
Bielawski MP, Goldstein KM, Mattocks KM, Bean-Mayberry B, Yano EM, Bastian LA. Improving care of chronic conditions for women veterans: identifying opportunities for comparative effectiveness research. Journal Of Comparative Effectiveness Research 2014, 3: 155-166. PMID: 24645689, DOI: 10.2217/cer.14.4.Peer-Reviewed Original ResearchConceptsComparative effectiveness researchChronic conditionsWomen veteransSystematic reviewEffectiveness researchPrior systematic reviewsLast systematic reviewChronic painClinical trialsCardiovascular diseaseLiterature searchRelevant articlesVeteransGender differencesDescriptive analysisHighlight studiesVast majorityPainHIVDiabetesReviewCancerDiseaseTrialsCare
2010
Cancer Screening Adherence
Gierisch J, Bastian L. Cancer Screening Adherence. 2010, 123-150. DOI: 10.1007/978-1-4419-5866-2_6.Peer-Reviewed Original ResearchBurden of cancerCancer Screening AdherenceNon-skin cancerScreening adherencePrimary preventionPhysical inactivityRisk factorsUnhealthy dietTobacco useSun exposureAlcohol consumptionScreening testCancerEarly detectionEffective optionGenetic mutationsBehavioral modificationSmall proportionBurdenObesityDiseasePrevention
2009
Responses to Online GSTM1 Genetic Test Results among Smokers Related to Patients with Lung Cancer: A Pilot Study
Sanderson SC, O'Neill SC, White DB, Bepler G, Bastian L, Lipkus IM, McBride CM. Responses to Online GSTM1 Genetic Test Results among Smokers Related to Patients with Lung Cancer: A Pilot Study. Cancer Epidemiology Biomarkers & Prevention 2009, 18: 1953-1961. PMID: 19567511, PMCID: PMC3417294, DOI: 10.1158/1055-9965.epi-08-0620.Peer-Reviewed Original ResearchConceptsSmoking cessation servicesLung cancer riskGenetic test resultsCessation servicesCancer riskLung cancerEffective smoking cessation servicesLower lung cancer riskPersonal genetic test resultsSignificant between-group differencesBetween-group differencesGenetic risk informationClinic settingSmokersSmokers' responsesCeiling effectsPilot studyGSTM1PatientsRiskCancerCessation-related cognitionsReal-time assessmentRisk informationFurther researchWhat Can Interest Tell Us about Uptake of Genetic Testing? Intention and Behavior amongst Smokers Related to Patients with Lung Cancer
Sanderson S, O’Neill S, Bastian L, Bepler G, McBride C. What Can Interest Tell Us about Uptake of Genetic Testing? Intention and Behavior amongst Smokers Related to Patients with Lung Cancer. Public Health Genomics 2009, 13: 116-124. PMID: 19556750, PMCID: PMC3696369, DOI: 10.1159/000226595.Peer-Reviewed Original ResearchConceptsLung cancer riskGenetic testingLung cancerGenetic testing intentionsCancer riskPsychosocial aspectsPositive attitudesChoices individualsLikert-style questionsTesting intentionsUntested assumptionsParticipantsHypothetical interestHypothetical scenariosMotivationBest predictorDaily Internet useTelephone surveySmokersIntentionPatientsAttitudesGenetic testsInternet useCancer
2008
The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes
O'Neill S, White D, Sanderson SC, Lipkus IM, Bepler G, Bastian LA, McBride CM. The feasibility of online genetic testing for lung cancer susceptibility: uptake of a web-based protocol and decision outcomes. Genetics In Medicine 2008, 10: 121-130. PMID: 18281920, DOI: 10.1097/gim.0b013e31815f8e06.Peer-Reviewed Original ResearchConceptsGenetic susceptibility testingLung cancerStudy websiteGenetic testingSusceptibility testingLung cancer susceptibilityCancer genetic testingEligible relativesBaseline interviewQuit motivationBaseline measuresBlood relativesWeb-based protocolCancer susceptibilityTelephone surveyOutcomesInformed decisionsCancerPredictors of Perceived Susceptibility of Breast Cancer and Changes Over Time: A Mixed Modeling Approach
McQueen A, Swank PR, Bastian LA, Vernon SW. Predictors of Perceived Susceptibility of Breast Cancer and Changes Over Time: A Mixed Modeling Approach. Health Psychology 2008, 27: 68-77. PMID: 18230016, PMCID: PMC2819176, DOI: 10.1037/0278-6133.27.1.68.Peer-Reviewed Original ResearchConceptsBreast cancerBreast symptomsCancer worryGreater cancer worryUS women veteransIntervention trialsMixed model analysisHealth behaviorsWomen veteransPercent riskHealth statusCancerPerceived susceptibilityGroup-level changesSingle-item measureAssess differencesPredictorsSymptomsEffect sizeIndividual variabilityDependent measuresGood targetConsistent predictorSusceptibilityModel effect sizes
2002
Hormone replacement therapy and the risk of death from breast cancer: A systematic review
Nanda K, Bastian LA, Schulz K. Hormone replacement therapy and the risk of death from breast cancer: A systematic review. American Journal Of Obstetrics And Gynecology 2002, 186: 325-334. PMID: 11854659, DOI: 10.1067/mob.2002.121077.Peer-Reviewed Original ResearchConceptsHormone replacement therapy usersHormone replacement therapyRisk of deathReplacement therapyBreast cancerTherapy usersCombined hormone replacement therapyRetrievable risk estimatesBreast cancer deathsCase-control studyRecency of useAscertainment of exposurePotential confoundersCancer deathRelative riskInclusion criteriaObservational studyHistologic conditionControl groupSystematic reviewProlonged durationTherapyProlonged useCancerRisk estimates
2001
Women's Interest in Chemoprevention for Breast Cancer
Bastian L, Lipkus I, Kuchibhatla M, Weng H, Halabi S, Ryan P, Skinner C, Rimer B. Women's Interest in Chemoprevention for Breast Cancer. JAMA Internal Medicine 2001, 161: 1639-1644. PMID: 11434796, DOI: 10.1001/archinte.161.13.1639.Peer-Reviewed Original ResearchConceptsBreast cancer riskBreast cancerCancer riskGail scoreObjective breast cancer riskMammography decision aidObjective risk factorsDevelopment of cancerAbsolute riskRisk factorsChemopreventive agentsChemopreventionCancerComparative riskTelephone interviewsTamoxifen citrateDrugsWomenRiskNatural agentsCommunity sampleDecision aidScoresTherapyAgents
1998
Promoting Informed Decision Making: Hormone Replacement Therapy
Bastian L, Couchman G, Rimer B, McBride C, Sutton L, Siegler I. Promoting Informed Decision Making: Hormone Replacement Therapy. Cancer Treatment And Research 1998, 97: 129-147. PMID: 9711414, DOI: 10.1007/978-0-585-30498-4_10.Peer-Reviewed Original ResearchConceptsHormonal replacement therapyReplacement therapyBreast cancerHormone replacement therapyRisk of cancerHRT useMenopausal symptomsMost gynecologistsHeart diseaseHigh riskNumber of womenAverage life expectancyCancerCancer issuesLife expectancyWomenMenopausePatientsTherapyRiskOsteoporosisGynecologistsSymptomsDiseasePhysicians